Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04836195
Title Phase I Trial of PCLX-001 in B-cell Non-Hodgkin Lymphoma and Advanced Solid Malignancies
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Pacylex Pharmaceuticals
Indications

lung non-small cell carcinoma

B-cell lymphoma

lung small cell carcinoma

urinary bladder cancer

breast cancer

mantle cell lymphoma

Burkitt lymphoma

colorectal cancer

diffuse large B-cell lymphoma

follicular lymphoma

Therapies

PCLX-001

Age Groups: adult | senior
Covered Countries CAN

Facility Status City State Zip Country Details
Cross Cancer Institute Recruiting Edmonton Alberta T6G 1Z2 Canada Details
Princess Margaret Hospital Recruiting Toronto Ontario M5G 2M9 Canada Details
Centre Hospitalier de l'Université de Montréal - CHUM Recruiting Montréal Quebec H2X 0C1 Canada Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field